OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Improving these processes involves adjusting various factors, including cell line engineering, media composition, and bioreactor conditions. A key goal is to maximize antibody production while reducing production fina